<?xml version="1.0" encoding="UTF-8"?>
<p>With respect to treatment of established infection, in the aforementioned macaque model, animals receiving pegylated IFN-α after exposure to SARS-CoV had outcomes intermediate between the prophylactically treated group and untreated controls [
 <xref rid="CIT0014" ref-type="bibr">14</xref>]. Most studies of treatment for severe MERS-CoV infection have not shown an association of IFN-α therapy with overall disease outcomes [
 <xref rid="CIT0017" ref-type="bibr">17</xref>]. However, a recurrent theme with all anti-infective drugs is that the time to administration is critical, and that treatment with IFN-α may have been delivered too late to attenuate the very high mortality of MERS-CoV.
</p>
